Search

Search Results

• 

  Anticoagulation in obese patients: challenges and strategies

  Alice Lipari, Esmeralda Capristo, Antonietta Ferretti, Erica De Candia

  18-09-2025

  https://doi.org/10.4081/btvb.2025.174

  2029

  PDF: 530

  HTML: 303

  XML: 186
• 

  Persistence of functional anti-PF4 antibodies and neutrophil activation in vaccine-induced immune thrombotic thrombocytopenia

  Eleonora Petito, Anna Maria Mezzasoma, Emanuela Falcinelli, Chiara Conti, Erica De Candia, Raimondo De Cristofaro, Silvia Sorrentino, Gian Marco Podda, Mariangela Scavone, Anna Falanga, Marina Marchetti, Luca Barcella, Stefania Basili, Lucia Stefanini, Andrea Boccatonda, Laura Contino, Patrizia Sciancalepore, Igor Florio, Egidio Imbalzano, Rossella Marcucci, Angela Rogolino, Patrizia Noris, Marta Panella, Rita Santoro, Maria Costanza Turi, Gaetano Vaudo, Rosa Curcio, Paolo Gresele

  18-11-2025

  https://doi.org/10.4081/btvb.2025.400

  959

  PDF: 176

  HTML: 201
• 

  Still unmet problems with low molecular weight heparin prophylaxis of venous thromboembolism. An Italian survey

  Stefania Cavazza, Gualtiero Palareti*

  03-10-2025

  https://doi.org/10.4081/btvb.2025.177

  1445

  PDF: 305

  HTML: 202

  Supplementary: 102
• 

  The key to fibrinolysis and thrombolysis

  Roger Lijnen, Désiré Collen

  09-09-2025

  https://doi.org/10.4081/btvb.2025.368

  1692

  PDF: 523

  HTML: 261

• PO095 | HEPARIN-INDUCED THROMBOCYTOPENIA PRESENTING AS A CIRCUIT-TRIGGERED PULMONARY SYNDROME IN HEMODIALYSIS: A CASE REPORT S.P. Colapietra, M. Gino | Osp. Molinette, Torino, Italy

  Selene Pia Colapietra

  26-10-2026

  https://doi.org/10.4081/btvb.2026.911

  6

  PDF: 3

• PO80 | Heparin-induced thrombocytopenia: a monocentric experience with danaparoid L. D’Innocenzo, S. Sorrentino, M. De Siati, A. Ferretti, E. De Candia | Unit of Haemostasis and Thrombosis Diseases, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.349

  693

  PDF: 13

• CO50 | Diagnostic accuracy of the heparin-induced multiple electrode aggregometry (HIMEA) functional test for heparin-induced thrombocytopenia M. Bovara¹, M. Sebastiani², Am. Gori^3,4, A. Rogolino^3,4, A. Bertelli^3,4, G. Ciarrocca Taranta^3,4, R. Marcucci^3,4, M. Sartori⁵, B. Cosmi⁵, M. Silingardi⁶, A. M. Pizzini⁶, A. Marrocchi¹, R. Mancini¹ | ¹Laboratorio Unico Metropolitano Ospedale Maggiore, AUSL Bologna; ²IRCCS Istituto delle Scienze Neurologiche, Bologna; ³Centro Malattie Aterotrombotiche Azienda Ospedaliera Universitaria Careggi, Firenze; ⁴Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze; ⁵U.O. di Angiologia e Malattie della Coagulazione dell’Azienda Ospedaliero Universitaria Policlinico S. Orsola-Malpighi, Bologna; ⁶Medicina Interna Ospedale Maggiore, Bologna, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.260

  618

  PDF: 17

• PO092 | HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH GUILLAIN-BARRÉ SYNDROME: A POSSIBLE LINK WITH IMMUNE DYSREGULATION S. Bernardi¹, F. Cei², R. Lavecchia³, L. Chiarugi⁴, R. Tarquini⁵ | ¹Università degli Studi di Firenze, Italy; ²Osp. S. Giuseppe Empoli, Italy

  Sofia Bernardi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.908

  8

  PDF: 2

• PO79 | Trying to hit the hit in the shadow of renal failure: a complex case managed with danaparoid S. Chessa^1,2, M. Anedda², M.V. Cherchi², M. Vacca^1,2, M. Caboni², J. Pilia², A.M. Bussu², M. Mantega², G. Costanzo¹, D. Firinu¹, S. Del Giacco¹, A. Mameli³, D. Barcellona³ | ¹Department of Medical Science and Public Health, University of Cagliari; ²Internal Medicine, ASL Sulcis, PO Sirai, Carbonia; ³Department of Medical Sciences and Public Health, Hemostasis and Thrombosis Unit, University of Cagliari and AOU of Cagliari, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.348

  656

  PDF: 10

• PO16 | Antithrombotic treatment and outcomes in retinal vein occlusion: a retrospective cohort study and comparison with historical group S.A. Malerba^1,2, M.T. Sartori¹, G. Libralon¹, C. Dalla Porta¹, P. Simioni¹ | ¹First Medical Clinic, Department of medicine- DIMED, Università degli Studi di Padova; ²Medicina Generale, Ospedale dell’Angelo, Mestre, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.277

  607

  PDF: 11
• 

  Antithrombotic therapy in idiopathic infertility

  Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

  03-10-2024

  https://doi.org/10.4081/btvb.2024.126

  3537

  PDF: 1262

• PO62 | Management of anticoagulation during extracorporeal circulation in a patient with APS T. Marrazzo¹, C. Marra², A. Caiazzo², I. Mattucci², L. Verniero³, N. Galdieri³, M.P. Ursi⁴, R. Albisinni⁵ | ¹UOC Medicina Interna e dei Trapianti, Ospedale Monaldi Azienda dei Colli, Napoli; ²UOSD di Cardiochirurgia dei Trapianti, Ospedale Monaldi Azienda dei Colli, Napoli; ³UOSD Terapia Intensiva di CCH Ospedale Monaldi Azienda dei Colli, Napoli; ⁴UOC MECAU Ospedale CTO Azienda dei Colli, Napoli; ⁵UOC CCH generale Ospedale Monaldi Azienda dei Colli, Napoli, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.331

  626

  PDF: 16
• 

  Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

  Bianca Clerici, Mariangela Scavone, Gian Marco Podda

  20-06-2024

  https://doi.org/10.4081/btvb.2024.127

  2854

  PDF: 851

• PO087 | BEYOND POSITIVITY: THE HIERARCHICAL ROLE OF IMMUNOASSAYS IN HEPARIN INDUCED THROMBOCYTOPENIA G. Murante^1|2|3, S. Bergonzi^1|2|3, M. Capetta^1|2|3, F. Valeri^1|2, C. Dainese^1|2, A. Valpreda⁴, R. Pastorino^1|3, F. Bocchi^1|3, A. Porreca⁵, B. Bruno^2|3, A. Borchiellini^1|2 | ¹Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza di Torino, Italy; ²Division of Hematology, AOU Città della Salute e della Scienza, Università di Torino, Italy; ³Dep. of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ⁴Central Lab. Baldi and Riberi, AOU Città della Salute e della Scienza di Torino, Italy; ⁵Dep. of Human Sciences and Quality of Life Promotion, Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Italy

  Giovanni Murante

  26-10-2026

  https://doi.org/10.4081/btvb.2026.903

  6

  PDF: 2

• CS08 | A combination of two rapid immunoassays improves HIT diagnosis G. Ciarrocca Taranta¹, A. Rogolino², A. Bertelli¹, A. Sorrentino¹, M. Di Gioia², F. Cesari², B. Giusti^1,2, E. Sticchi^1,2, M. Berteotti^1,2, A.M. Gori^1,2, R. Marcucci^1,2 | ¹Department of Experimental and Clinical Medicine, University of Firenze; ²Atherothrombotic Disease Unit, Careggi University Hospital, Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.205

  701

  PDF: 15

• PO111 | A RARE CASE OF ACUTE PROMYELOCYTIC LEUKAEMIA PRESENTING WITH A PURELY THROMBOTIC DISSEMINATED INTRAVASCULAR COAGULATION PHENOTYPE L. Colavolpe, M. Provisione, L. Appio, S. Tupputi, N. Mumoli | ASST Valle Olona, Busto Arsizio, VA, Italy

  Lucia Colavolpe

  26-10-2026

  https://doi.org/10.4081/btvb.2026.927

  7

  PDF: 2
• 

  Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review

  Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo

  24-10-2022

  https://doi.org/10.4081/btvb.2022.44

  1476

  PDF: 411

• PO002 | VENOUS THROMBOEMBOLISM IN PATIENTS WITH FACTOR VII DEFICIENCY: A CASE SERIES AND REVIEW OF THE LITERATURE BM. Roccon¹, MI. Tassoni¹, G. Quintavalle¹, F. Riccardi¹, A. Matichecchia¹, GF. Rivolta¹, M. Lombardi³, R. Rossi², A. Benegiamo², A. Tagliaferri¹, A. Coppola¹ | ¹SSD Centro Hub Emofilia e Malattie Emorragiche Congenite, Azienda Ospedaliero-Universitaria di Parma, Italy; ²Lab. di Coagulazione, UOC Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria di Parma, Italy; ³Centro Emostasi, UOC Medicina Interna ad indirizzo angiologico e coagulativo, Azienda Ospedaliero-Universitaria di Parma, Italy

  Antonio Coppola

  26-10-2026

  https://doi.org/10.4081/btvb.2026.818

  7

  PDF: 1
• 

  A case of inadvertent overdose with argatroban in a 13-month-old toddler in the cardiac catheterization lab setting

  Charles E. Mahan

  28-08-2026

  https://doi.org/10.4081/btvb.2026.567

  332

  PDF: 107

• CO049 | RANDOMIZED CONTROLLED TRIAL TO IDENTIFY THE OPTIMAL SCHEME OF HEPARIN FOR TREATMENT OF DEEP VEIN THROMBOSIS IN PREGNANCY E. Grandone^1|3, E. Antonucci², A. de Laurenzo¹, L. Latino¹, M. Mastroianno¹, G. Tiscia¹, M. Margaglione³, P. Prandoni² | ¹IRCCS Casa Sollievo della Sofferenza, S.Giovanni Rotondo, Italy; ²Fondazione Arianna, Italy; ³Università di Foggia, Italy

  Elvira Grandone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.751

  9

  PDF: 2
• 

  Perioperative management of patients taking direct oral anticoagulants: challenges in high-bleed-risk surgery and neuraxial anesthesia

  Maria P. Ntalouka, Eleni M. Arnaoutoglou, James D. Douketis

  28-08-2026

  https://doi.org/10.4081/btvb.2026.471

  480

  PDF: 243
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  https://doi.org/10.4081/btvb.2024.111

  2140

  PDF: 1368

• PO009 | THROMBOPHILIA AND ASSISTED REPRODUCTIVE TECHNOLOGY: PRELIMINARY RESULTS FROM A SINGLE CENTER RETROSPECTIVE COHORT STUDY G. Burrei², E. Malloggi¹, S. Moruzzi¹, L. Delfino¹, F. Pizzolo¹, L. Panepinto¹, F. Presa¹, C. Spillere¹, A. Moschella¹, F. Zoccatelli¹, S. Friso¹, N. Martinelli¹, S. Suardi¹ | ¹Department of Medicine, University Hospital, Verona, Italy; ²General Medicine Unit, Magalini Hospital, Villafranca di Verona, Italy

  Giulia Burrei

  26-10-2026

  https://doi.org/10.4081/btvb.2026.825

  7

  PDF: 2

• PO077 | BALANCING BLEEDING AND THROMBOSIS: SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN THROMBOPROPHYLAXIS IN PATIENTS WITH HEMOPHILIA UNDERGOING MAJOR SURGERY S. Bergonzi^1|2|3, G. Murante^1|2|3, M. Capetta^1|2|3, F. Valeri^1|2, C. Dainese^1|2, A. Valpreda^3|4, R. Pastorino^3|4, F. Bocchi^3|4, B. Bruno^2|3, A. Borchiellini^1|2 | ¹Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza, Turin, Italy; ²Division of Hematology, AOU Città della Salute e della Scienza, Università di Torino, Italy; ³Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ⁴Central Laboratory Baldi and Riberi, AOU Città della Salute e della Scienza, Università di Torino, Italy

  Sara Bergonzi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.893

  6

  PDF: 2
• 

  Mortality following major gastrointestinal bleeding among patients receiving direct oral anticoagulants

  Julia Sharobim, Tzu-Fei Wang, Marc Carrier

  16-04-2026

  https://doi.org/10.4081/btvb.2026.432

  818

  PDF: 157
• 

  Aspirin or low-molecular weight heparin for thromboprophylaxis after a fracture? That is the question

  Giuseppe Camporese, Paolo Prandoni, Walter Ageno

  17-05-2023

  https://doi.org/10.4081/btvb.2023.82

  1484

  PDF: 722

• CO-73 | WHEN BLEEDING MIMICS THROMBOSIS: DIAGNOSTIC DELAY AND THROMBOTIC COMPLICATIONS IN ACQUIRED HEMOPHILIA A R. Tomasello¹, M. Mattana¹, S. Raso¹, F. Schirò¹, P. Polidori², M.I. Di Lena³, F. La Gattuta⁴, M. Napolitano¹ | ¹Ematologia e malattie rare, PO Cervello di Palermo, Italy; ²Farmacia ospedaliera, PO Cervello di Palermo, Italy; ³Direzione medica, PO Cervello di Palermo, Italy; ⁴Radiologia interventistica, PO Villa Sofia di Palermo, Italy

  Riccardo Tomasello

  14-10-2026

  https://doi.org/10.4081/btvb.2026.683

  31

  PDF: 10
• 

  Executive summary of the SISET position paper on the management of antithrombotic therapy in left ventricular thrombus

  Emanuele Valeriani, Arianna Pannunzio, Danilo Menichelli, Domenico Prisco, Walter Ageno, Daniele Pastori, Pasquale Pignatelli

  16-12-2025

  https://doi.org/10.4081/btvb.2025.401

  464

  PDF: 134

  HTML: 111

• PO155 | MANAGEMENT OF ANTICOAGULANT THERAPY IN IMMUNOTHROMBOSIS SECONDARY TO TOXOPLASMA INFECTION A. Grembiale¹, A. Sabena¹, G. Dettori¹, C. Grendene¹, S. Grazioli¹, S. Venturini² | ¹SOC Medicina Interna 2 - Azienda Sanitaria Friuli Occidentale - Pordenone, Italy; ²SSD Malattie Infettive - Azienda Sanitaria Friuli Occidentale - Pordenone, Italy

  Alessandro Grembiale

  26-10-2026

  https://doi.org/10.4081/btvb.2026.971

  8

  PDF: 2
• 

  Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

  Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan

  17-10-2022

  https://doi.org/10.4081/btvb.2022.41

  2853

  PDF: 491

  Supplementary Files: 144

• CO-24 | BALANCING BLEEDING AND THROMBOSIS: SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN THROMBOPROPHYLAXIS IN PATIENTS WITH HEMOPHILIA UNDERGOING MAJOR SURGERY S. Bergonzi^1|2|3, G. Murante^1|2|3, M. Capetta^1|2|3, F. Valeri^1|2, C. Dainese^1|2, A. Valpreda^3|4, R. Pastorino^3|4, F. Bocchi^3|4, B. Bruno^2|3, A. Borchiellini^1|2 | ¹Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza, Torino, Italy; ²Division of Hematology, AOU Città della Salute e della Scienza, University of Turin, Italy; ³Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ⁴Central Laboratory Baldi and Riberi, AOU Città della Salute e della Scienza, University of Turin, Italy

  Sara Bergonzi

  14-10-2026

  https://doi.org/10.4081/btvb.2026.634

  27

  PDF: 13
• 

  Vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1 nCoV-19 vaccine: report of two cases

  Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò

  23-05-2022

  https://doi.org/10.4081/btvb.2022.23

  4530

  PDF: 0

• PO160 | THE USE OF ANTIDEPRESSANT DRUGS AND BENZODIAZEPINE HYPNOTICS AS AN UNUSUAL RISK FACTOR FOR VTE G. Chiarelli, C. Caputo, M. Romeo, F. Strano, P. Conca, P. Rufolo, M.G. Mazzone, R. Russo, L. Valletta Jr., G. D’Errico, C. De Luca, E. Cimino, A. Tufano | DMCC. "Federico II" University of Naples, Italy

  Antonella Tufano

  26-10-2026

  https://doi.org/10.4081/btvb.2026.976

  7

  PDF: 2

• PO36 | Venous stenting for symptomatic iliac thrombosis: five-years experience of single center I. Nichele¹, G. Marchesini¹, L. Boi², G. Carli¹, A. Tosetto¹ | ¹Hemophilia and Thrombosis Center, Hematology Department, S. Bortolo Hospital, Vicenza; ²Radiology Department, Ospedale Ca’ Foncello, Treviso, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.299

  622

  PDF: 26

• PO085 | ACQUIRED HEMOPHILIA A IN THE SURGICAL PATIENT: DIAGNOSTIC AND THERAPEUTIC COMPLEXITY M. Luongo¹, P. Massaro¹, M. Di Mascio¹, P.G. Simeone², F. Santilli², S. Verna¹ | ¹Immunohematology Service, Asl 02 Abruzzo, Chieti, Italy; ²Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti–Pescara, Italy

  Myriam Luongo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.901

  7

  PDF: 2
• 

  The therapeutic landscape of cancer-associated splanchnic vein thrombosis

  Alessia Abenante, Filippo Catalani, Walter Ageno

  16-04-2026

  https://doi.org/10.4081/btvb.2026.458

  311

  PDF: 153

• CO-77 | PERINATAL MANAGEMENT IN WOMAN WITH MILD HEMOPHILIA B: A TWIN PREGNANCY CASE T. Martini¹, B. Borsellino^1|2, B. Pollio¹ | ¹Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Torino, Italy; ²Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Roma, Italy

  Tiziano Martini

  14-10-2026

  https://doi.org/10.4081/btvb.2026.687

  25

  PDF: 12

• PO122 | SUCCESSFUL MANAGEMENT OF THERAPEUTIC ANTICOAGULATION FOR PROVOKED VENOUS THROMBOEMBOLISM IN A PATIENT WITH FACTOR VII DEFICIENCY AND SEPTIC SHOCK S. Birocchi¹, F.M. Monda¹, B. Clerici^1|2, M. Scavone², R. Cabiddu¹, E. Pontisso¹, C. Ortelli¹, M.L.G. Perego¹, E. Fiorini¹, L. Catarini¹, A. Bortoli¹, M. Manzoni¹, F.M. Casanova¹, A. Tripodi^2|3, F. Peyvandi^2|3, G.M. Podda^1|2 | ¹S.C. Medicina Generale 2, Ospedale San Paolo, ASST Santi Paolo e Carlo, Milano, Italy; ²Dipartimento di Scienze della Salute, Università degli Studi di Milano, Italy; ³Centro di riferimento emofilia e trombosi "Emilio Bianchi"; ⁴S. Birocchi and F.M. Monda contributed equally as co-first authors

  Simone Birocchi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.938

  7

  PDF: 2
• 

  PO29 | CANADIAN INSIGHTS INTO THE MANAGEMENT OF BREAKTHROUGH THROMBOSIS S. Ramdani¹, C. Séguin² | ¹Division of Hematology, Post-Graduate Medical Education Program, McGill University, Montreal; ²Division of Hematology, Department of Medicine, McGill University Health Center, Montreal, Canada

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.524

  482

  PDF: 97

• PO159 | HOW DOES DRUG ABSORPTION CHANGE IN THE PRESENCE OF NEOPLASTIC GASTROINTESTINAL DISEASE? M. Gagliardi, L. Capone, A. Ciampa | Centro Emostasi, AORN Moscati, Avellino, Italy

  Mariachiara Gagliardi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.975

  5

  PDF: 3
• 

  Beyond the usual workup: severe hypertriglyceridemia as a potential cause of cerebral venous thrombosis

  Arnaud Lapostolle, Randa Khani-Bittar, Julie Mazoyer, Astrid De Liege, Bertrand Degos

  15-07-2026

  https://doi.org/10.4081/btvb.2026.477

  351

  PDF: 48

• PO22 | Early detection and management of PICC-related thrombosis in oncohematologic patients through serial ultrasound monitoring: a prospective observational study S. Laurenti, M. Schneeberger, G. Rosati, A. Pozzi, M. Padrini, R. Vacchelli, A. Morotti | University of Turin, AUO San Luigi Gonzaga, Orbassano (TO), Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.282

  636

  PDF: 27

• PO77 | The clinical awareness of mixing test interpretation in the era of complex reporting algorithm: do we forget the origins? A. Fassina, L. De Valentin, S. Luzi, R. Turrini, A. Antico, L. Zardo | Laboratorio Analisi Castelfranco Veneto, ULSS Marca Trevigiana, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.346

  627

  PDF: 16
• 

  PO28 | CLINICAL IMPLICATIONS OF ANTICOAGULANT DRUG INTERACTIONS WITH TARGETED AND IMMUNE THERAPIES IN ONCOLOGY: A CONTEMPORARY RISK STRATIFICATION FRAMEWORK D. Dhami¹, C. Solowiej Singh ¹, M. Dhami ² | ¹Abrazo Internal Medicine Residency; ²Eastern Connecticut Hematology Oncology, Norwich, CT, USA

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.523

  569

  PDF: 102
• 

  Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

  Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

  13-12-2024

  https://doi.org/10.4081/btvb.2024.131

  3343

  PDF: 456

• PO003 | CATHETER-RELATED THROMBOSIS IN CANCER PATIENTS: A RETROSPECTIVE REAL-WORLD STUDY G. Autiero^1|3, S.A. Malerba^1|2|4, F. Busato^1|2, D. Tolomio^1|2, M. Dalla Vestra^1|2, F. Presotto^1|2 | ¹U.O. Medicina Generale, Osp. Dell'Angelo, Venezia-Mestre, Italy; ²U.O. Angiologia, Osp. Dell'Angelo, Venezia-Mestre, Italy; ³Dip. Medicina Interna, Università degli Studi di Padova, Italy; ⁴U.O.C. Medicina Generale ad indirizzo trombotico ed emorragico, Università degli studi di Padova, Italy

  Giuliana Autiero

  26-10-2026

  https://doi.org/10.4081/btvb.2026.819

  5

  PDF: 2

• PO94 | The use of antidepressant drugs and benzodiazepine hypnotics as an unusual risk factor for VTE G. Chiarelli, F. Strano, P. Conca, P. Rufolo, M. G. Mazzone, R. Russo, L. Jr Valletta, G. D’Errico, C. De Luca, E. Cimino, A. Tufano, M.N.D. Di Minno | Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.364

  740

  PDF: 21

• PO156 | DIRECT ORAL ANTICOAGULANTS FOR THE TREATMENT OF VTE IN PATIENTS WITH CANCER: A SURVEY AMONG CAMPANIAN INTERNAL MEDICINE WARDS E. Marrone¹, C. Arturo², F. Cannavacciulo³, D. D’Ambrosio⁴, F. Gallucci¹, M. Amitrano³, C. Di Gennaro², P. Morella¹, A. Maffettone⁵ | ¹UOC Medicina 3, AORN A Cardarelli, Napoli, Italy; ²UOC Medicina Generale, PO A. Rizzoli, Ischia, Italy; ³UOC Medicina Interna, AO Moscati, Avellino, Italy; ⁴UOC Medicina Generale, PO Piedimonte Matese ASL Caserta, Italy; ⁵UOC Medicina interna, PO San Luca, Vallo Della Lucania ASL Salerno, Italy

  Emiliana Marrone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.972

  5

  PDF: 2
• 

  PO61 | RISK FACTORS FOR INTRACRANIAL HEMORRHAGE: AN UMBRELLA REVIEW TO INFORM MACHINE LEARNING PREDICTION MODELS IN GLIOMA PATIENTS RECEIVING ANTICOAGULATION T.A. Adeyemo, S. Greenley, F. Ware, W. Jones, A. Maraveyas, F. Haque | ¹Centre of Excellence for Data Science, Artificial Intelligence and Modelling DAIM, Faculty of Science and Engineering, University of Hull, UK; ²Hull York Medical School, Hull, UK; ³Academic Library Services, University of Hull, UK; ⁴NHS Humber Health Partnership, Hull, UK

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.552

  519

  PDF: 115

• PO072 | DIAGNOSTIC CHALLENGES IN THROMBOTIC MICROANGIOPATHY: A CASE OF ATYPICAL HEMOLYTIC UREMIC SYNDROME M. Moretti¹, R. Gervasi², E. Rossini², G.F. Romiti¹, P. Carfagna², S. Basili¹, P. Battisti² | ¹Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma, Italy; ²Azienda Ospedaliera San Giovanni Addolorata, Roma, Italy

  Margherita Moretti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.888

  6

  PDF: 2

• CO-66 | PREGNANCY OUTCOMES AND PERIPARTUM MANAGEMENT IN WOMEN WITH CONGENITAL FIBRINOGEN DISORDERS: A SINGLE-CENTRE EXPERIENCE T. Martini¹, B. Borsellino^1|2, B. Pollio¹ | ¹Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Torino, Italy; ²Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Roma, Italy

  Tiziano Martini

  14-10-2026

  https://doi.org/10.4081/btvb.2026.676

  28

  PDF: 13

• PO64 | A silent hemorrhage in the immuno-thrombotic chaos of antiphospholipid syndrome G. Autiero, S.A. Malerba, A. Malaguti, M. Dalla Vestra, F. Presotto | Medicina Generale, Ospedale dell’Angelo, Mestre-Venezia, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.333

  652

  PDF: 16

• PO108 | DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH VENOUS THROMBOEMBOLISM RECEIVING LONG-TERM IMMUNOSUPPRESSIVE THERAPY AFTER LIVER AND KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE U. Mazzarelli¹, L. Agrelli¹, A. Cirillo¹, C. Crescenzo², M. Triggiani¹, A. Guida³ | ¹Dipartimento di Medicina Interna, Università degli studi di Salerno, Italy; ²UOC Nefrologia e Trapianti di rene; ³Centro per le malattie emorragiche congenite e malattie trombotiche, AOU San Giovanni di Dio e Ruggi d'Aragona Salerno, Italy

  Anna Guida

  26-10-2026

  https://doi.org/10.4081/btvb.2026.924

  6

  PDF: 2
• 

  PO19 | THE INTER-RELATIONSHIP BETWEEN NETOSIS, THE ADAMTS-13/VWF AXIS, AND HEMOSTATIC ACTIVATION IN PATIENTS WITH GYNECOLOGICAL MALIGNANCIES: PROGNOSTIC SIGNIFICANCE AND IMPACT OF CHEMOTHERAPY A. Makatsariya¹, E. Beloborodova²,V. Bitsadze¹, J. Khizroeva¹, A. Vorobev¹, A. Solopova¹, M. Tretyakova¹, N. Gashimova¹, K. Grigoreva¹, A. Oskolkova¹, J. Christophe Gris^1|3, I. Elalamy^1|4|5, G. Gerotziafas^1|4|5 | ¹Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children’s Health, I. M. Sechenov First Moscow State Medical University Sechenov University, Moscow, Russia; ²MEDSI Network of Medical Centers, Moscow, Russia; ³Faculty of Pharmaceutical and Biological Sciences, Montpellier University, France; ⁴Department Hematology and Thrombosis Center, Medicine Sorbonne University, Paris, France; ⁵Hospital Tenon, Paris, France

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.514

  464

  PDF: 94

• PO92 | Challenging management of portal vein thrombosis in a cirrhotic patient on hormone therapy after breast cancer L. Jr Valletta, C. De Luca, M. Aversano, C. Caputo, E. Cimino, P. Conca, A. Tufano, M.D. Di Minno | AOU Federico II Napoli, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.362

  563

  PDF: 18
• 

  PO40 | RADAR, UK-MRA MYELOMA XV - COMPARING MRD-GUIDED TREATMENT ESCALATION AND DE-ESCALATION STRATEGIES IN PATIENTS WITH NEWLY DIAGNOSED MYELOMA SUITABLE FOR STEM CELL TRANSPLANTATION: THROMBOPROPHYLAXIS SUBGROUP STUDY PROTOCOL Z. Sayar, on behalf of the RADAR Investigators | Whittington Health NHS Trust and Royal Free Hospital, London, UK

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.534

  479

  PDF: 109

• PO07 | Liver transplant in a case of congenital afibrinogenemia G. Murante^1,2,3, S. Bergonzi^1,2,3, C. Sella^1,2,3, F. Valeri^1,2, C. Dainese^1,2, A. Valpreda⁴, R. Pastorino^1,3, R. Romagnoli⁵, D. Patrono⁵, D. Cussa⁵, S. Martini⁶, B. Bruno^2,3, A. Borchiellini^1,2 | ¹Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza, Torino; ²Division of Hematology, AOU Città della Salute e della Scienza, University of Turin; ³Department of Molecular Biotechnology and Health Sciences, University of Turin; ⁴Central Laboratory Baldi and Riberi, AOU Città della Salute e della Scienza, Torino; ⁵General Surgery 2U - Liver Transplant Center, Molinette Hospital, AOU Città della Salute e della Scienza, Torino; ⁶SSD Hepatic insufficiency and Liver Transplant, AOU Città della Salute e della Scienza, Torino, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.269

  577

  PDF: 15

• PO070 | INFECTIVE ENDOCARDITIS AND ISCHEMIC CEREBRAL EVENTS IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND TRIPLE ANTIPHOSPHOLIPID POSITIVITY: THE ROLE OF ANTICOAGULATION IN PRIMARY PREVENTION T. Marrazzo¹, M.P. Ursi², R. Andini¹, R. Albisinni³ | ¹UOC Med Interna e dei Trapianti; ²UOC Mecau; ³UOC CCH generale, Osp. Monaldi AORN dei Colli, Napoli, Italy

  Tommaso Marrazzo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.886

  8

  PDF: 2
• 

  Diagnostic and management practices for inherited fibrinogen disorders: a nationwide survey of Italian Hemophilia Treatment Centers

  Renato Marino, Silvia Linari, Marzia Leotta, Antonio Coppola, Chiara Biasoli, Maria Elisa Mancuso, Flora Peyvandi, Cristina Santoro, Ezio Zanon, Rita Carlotta Santoro

  02-12-2025

  https://doi.org/10.4081/btvb.2025.372

  920

  PDF: 119

  HTML: 122

  Supplementary: 79

  Appendix: 79

• CO-28 | SYNERGISTIC EFFECT OF RECOMBINANT FACTOR INFUSION ON THROMBIN GENERATION IN HEMOPHILIA PATIENTS UNDER EMICIZUMAB OR CONCIZUMAB PROPHYLAXIS F. Bocchi^1|2, R. Pastorino^1|2, G. Murante^1|2|3, S. Bergonzi^1|2|3, M. Capetta^1|2|3, F. Valeri^2|3, C. Dainese^2|3, A. Valpreda⁴, B. Bruno^1|3, A. Borchiellini^2|3 | ¹Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ²Regional Centre for Thrombotic and Hemorrhagic Diseases, AOU Città della salute e della Scienza di Torino, Italy; ³Division of Hematology, AOU Città della Salute e della Scienza, University of Turin, Italy; ⁴Central Lab Baldi and Riberi, AOU Città della salute e della Scienza di Torino, Italy

  Francesca Bocchi

  14-10-2026

  https://doi.org/10.4081/btvb.2026.638

  30

  PDF: 19
• 

  OC06 | PRIMARY THROMBOPROPHYLAXIS IN ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA UNDERGOING SYSTEMIC ANTICANCER TREATMENT: A CANCER-CENTER COHORT STUDY ON CLINICAL PRACTICE AND OUTCOMES F. Haque^1|2, A. Adekeye^1|2, Z. Mohtashim², K. Page¹, M. Goodman¹, A. Maraveyas ^1|2 | ¹Hull University Teaching Hospital NHS Trust, UK; ²Hull York Medical School, UK

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.490

  476

  PDF: 106

• CO113 | AN OBSERVATIONAL STUDY ON THE EFFECT OF HEMODIALYSIS MEMBRANES ON ENDOGENOUS THROMBIN POTENTIAL IN END-STAGE RENAL DISEASE PATIENTS Z. Saeed^1|4, O. Ndrecka², V. Sirolli², M. Bonomini², P. Lanuti^1|3, S. Gallina⁴, G. Rend^1|4 | ¹Center for Advanced Studies and Technology, G. d’Annunzio University of Chieti-Pescara, Chieti, Italy; ²Nephrology and Dialysis Unit, Department of Medicine, G. d’Annunzio University of Chieti-Pescara, SS. Annunziata Hospital, Chieti, Italy; ³Department of Medicine and Aging Sciences, G. d’Annunzio University of Chieti-Pescara, Chieti, Italy; ⁴Department of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University of Chieti-Pescara, Chieti, Italy

  Zeeba Saeed

  26-10-2026

  https://doi.org/10.4081/btvb.2026.815

  7

  PDF: 2

• PO91 | Disseminated intravascular coagulation with deep vein thrombosis in a frail patient: an extreme manifestation triggered by sepsis during SGLT2i therapy M. Vacca¹, M.V. Cherchi¹, S. Che¹, G.A.M.L. Costanzo², D. Firinu², M. Mantega¹, S. Del Giacco² | ¹Ospedale Sirai, ASL Sulcis, ²Università degli Studi di Cagliari, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.361

  794

  PDF: 19

• PO150 | FACTOR XII DEFICIENCY IN THE SETTING OF RECURRENT THROMBOSIS AND EXTENDED VENOUS OBSTRUCTION: A CASE ANALYSIS L. Leoni¹, G. Pata¹, A. Domenighini¹, L. Crippa², T. D'aliberti¹, G. Galimberti¹, F. Paciullo¹, P. Rovere Querini¹ | ¹Internal Medicine Unit; ²Coagulation Service Thrombosis Research Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy

  Laura Leoni

  26-10-2026

  https://doi.org/10.4081/btvb.2026.966

  7

  PDF: 2
• 

  PO35 | A MULTICENTRE AUDIT OF CURRENT TUMOUR THROMBOSIS MANAGEMENT IN THE UNITED KINGDOM A.A. Bhatti¹, L. Tafesh¹, A. Waton¹, M. Thomas³, N. Prasannan³, A. Bhide³, R. Walsh³, T. Lucas³, K. White⁴, T. Bariana⁴, O. Tsiamita⁴, S. Soman⁴, P. Woolley⁵, I. Lacej⁵, K. Musgrave^1|2 | ¹Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; ²Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; ³University College London Hospitals NHS Foundation Trust, London, UK; ⁴Barts Health NHS Trust, London, UK; ⁵Imperial College Healthcare NHS Trust, London, UK

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.529

  464

  PDF: 99

• PO066 | ONE IN TWO MILLION: A 'DOUBLE-HIT' CASE OF INFRARENAL VENA CAVA AGENESIS AND TRIPLE-POSITIVE ANTIPHOSPHOLIPID SYNDROME N. Portesi, S. Pontoglio, G. Martini | ASST Spedali Civili di Brescia, Italy

  Nicola Portesi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.882

  8

  PDF: 3
• 

  Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

  Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

  23-05-2022

  https://doi.org/10.4081/btvb.2022.28

  5762

  PDF: 667

  APPENDIX: 0

• PO59 | Efficacy and safety of different anticoagulant treatment regimens for isolated internal jugular vein thrombosis: a case series A. Pannunzio¹, E. Valeriani¹, I.M. Palumbo¹, S. Marucci², D. Menichelli¹, D. Pastori², P. Pignatelli² | ¹Department of General Surgery and Surgical Specialty, Sapienza University of Roma; ²Department of Clinical, Internal Medicine, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.328

  691

  PDF: 31
• 

  OC05 | TIME TO START OF ANTICOAGULANT THERAPY AND SURVIVAL OUTCOMES IN CANCER PATIENTS WITH PULMONARY EMBOLISM K. Bria, B. Gage, M. Bealsey, K. Sanfilippo | Washington University in St. Louis School of Medicine, St. Louis, MO, USA

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.489

  500

  PDF: 109
• 

  Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

  Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

  16-05-2024

  https://doi.org/10.4081/btvb.2024.118

  1900

  PDF: 1304

• CO102 | VARIABILITY IN ANTIPHOSPHOLIPID ANTIBODY TESTING AND TREATMENT STRATEGIES IN OBSTETRIC ANTIPHOSPHOLIPID SYNDROME: RESULTS FROM THE OAPS-CARE SURVEY, ON BEHALF OF THE EUROPEAN FORUM ON ANTIPHOSPHOLIPID ANTIBODIES A. Hoxha^1|2, E. Esteve-Valverde^3|4, G. Gobbo^1|2, F. Miró-Mur⁴, M. Radin⁵, S. De Carolis⁶, C. Trilla^7|8|9|10, A. Tincani^11|12, R. Cervera^13|14, J. Alijotas-Reig^3|15|16 | ¹Department of Medicine - DIMED, University of Padua, Padova, Italy; ²Internal Medicine Unit, Thrombosis and Bleeding Disorder, University Hospital of Padua, Padova, Italy; ³Systemic Autoimmune Diseases Unit. Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari Alt-Penedes-Garraf, Sant Pere de Ribas, Barcelona, Spain; ⁴Systemic Autoimmune Disease Research Unit. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain; ⁵Center of Research of Immunopathology and Rare Diseases - Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, SCDU Nephrology and Dialysis, School of Specialization of Clinical Pathology, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Torino, Italy; ⁶Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Scienze per la salute della Donna e del Bambino e di Sanità Pubblica, Roma, Italy; ⁷Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; ⁸Universitat Autònoma de Barcelona, Barcelona, Spain; ⁹Spanish Network in Maternal, Neonatal, Child and Developmental Health Research (RICORS-SAMID, RD24/0013/0001), Instituto de Salud Carlos III, 28040 Madrid, Spain; ¹⁰Women and Perinatal Health Research Group, Institut de Recerca (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain; ¹¹Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili, Brescia, Italy; ¹²Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; ¹³Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; ¹⁴August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Catalonia, Spain; ¹⁵Department of Medicine. Universitat Autonoma de Barcelona, Barcelona, Spain; ¹⁶Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Barcelona, Spain

  Ariela Hoxha

  26-10-2026

  https://doi.org/10.4081/btvb.2026.804

  8

  PDF: 2

• PO81 | Direct oral anticoagulants in atypical site vein thrombosis: a single centre experience focused on cancer patients U. Mazzarelli¹, A. Guida¹, L. Agrelli¹, M. Amato¹, R. Guarrasi², L. Santaniello², C. Cardamone¹, P. Vitale¹, M. Triggiani¹ | ¹Centro per le Malattie Emorragiche Congenite e Malattie Trombotiche UOC Clinica Immunologica e Reumatologica AOU S. Giovanni di Dio e Ruggi d’Aragona, Salerno; ²UOC Clinica Oncologica AOU S. Giovanni di Dio e Ruggi d’Aragona, Salerno, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.350

  631

  PDF: 23

• PO149 | MANAGEMENT OF ANTITHROMBOTIC THERAPY IN A PATIENT WITH HEMOPHILIA C AND ATRIAL FIBRILLATION E. Marrone¹, G. Ruggiero², E. Cimino³, P. Conca³, C. Miele⁴, F. Gallucci¹, A. Abate¹, C. Romano¹, D. Leosco², U. Valentino¹ | ¹Department of Medicine 3, Cardarelli Hospital, Napoli, Italy; ²School of Specialization in Geriatrics; ³Department of Internal Medicine and Blood Coagulation; ⁴Department of Laboratory Medicine and Transfusion, Federico II University, Napoli, Italy

  Emiliana Marrone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.965

  6

  PDF: 2
• 

  PO34 | INVESTIGATORS’ DECISIONS ON ANTICOAGULATION AFTER EXTENDED API-CAT TREATMENT FOR CANCER VENOUS THROMBOEMBOLISM I. Mahé^1|4, F. Happe², M. Monreal^5|7, H. Robert-Ebadi⁸, P. Debourdeau⁹, J. R. Fabreguettes¹⁰, S. Accassat¹¹, P. Mismetti^4|11|12, P. Girard¹³, S. Laporte^4|12|14, C. Chapelle¹⁴ | ¹Paris Cité University; ²Assistance Publique - Hôpitaux de Paris, Louis Mourier Hospital, Department of Internal Medicine; ³Inserm UMR-S970, Paris Cardiovascular Research Center, Team « Endotheliopathy and Hemostasis Disorders », Paris, France; ⁴F-CRIN INNOVTE Network, France; ⁵Department of Internal Medicine, Institut de Recerca Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; ⁶Department of Medicine, Universitat Autonoma de Barcelona, Barcelona; ⁷Universidad Catolica San Antonio de Murcia, Murcia, Spain; ⁸Division of Angiology and Hemostasis, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland; ⁹Arles Hospital, Oncology unit, Arles, France; ¹⁰Assistance Publique - Hôpitaux de Paris, AGEPS, France; ¹¹Service de Médecine Vasculaire et Therapeutique, CHU de Saint-Etienne, Saint-Etienne, France; ¹²Université Jean Monnet, Mines Saint-Étienne, INSERM Unité 1059, Santé Ingénierie Biologie Saint-Étienne SAINBIOSE, Saint-Étienne, France; ¹³Département de Pneumologie, Institut Mutualiste Montsouris, Paris; ¹⁴Service de Pharmacologie Clinique, CHU de Saint-Etienne, Saint-Etienne, France

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.528

  423

  PDF: 90

• CO11 | Oral anticoagulation with vitamin K antagonists in early childhood: a single centre-experience B. Borsellino^1,2, B. Pollio¹, I. Ricca¹, R. Albiani¹, T. Martini¹ | ¹Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Torino; ²Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Roma Tor Vergata, Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.215

  706

  PDF: 25

• PO056 | SYNERGISTIC EFFECT OF RECOMBINANT FACTOR INFUSION ON THROMBIN GENERATION IN HEMOPHILIA PATIENTS UNDER EMICIZUMAB OR CONCIZUMAB PROPHYLAXIS F. Bocchi^1|2, R. Pastorino^1|2, M. Capetta^1|2|3, S. Bergonzi^1|2|3, G. Murante^1|2|3, F. Valeri^2|3, C. Dainese^2|3, A. Valpreda⁴, B. Bruno^1|3, A. Borchiellini^2|3 | ¹Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ²Regional Center for Thrombotic and Hemorrhagic Diseases; ³Division of Hematology; ⁴Central Lab Baldi and Riberi, AOU Città della Salute e della Scienza di Torino, Italy

  Matilde Capetta

  26-10-2026

  https://doi.org/10.4081/btvb.2026.872

  7

  PDF: 2

• CO41 | Failure in assisted reproductive techniques: insights from the first registry E. Grandone^1,3,4, C. Lodigiani², D. Colaizzo³, M. Passaretti², J. Khizroeva⁴, A. De Laurenzo³, P. Totaro⁵, E. Bucherini⁶, D. Baldini⁷, V. Bitsadze⁴, A. Makatsarya⁴, M. Mastroianno³, G. Piazza⁸, M. Othman⁹, M. Margaglione¹ | ¹University of Foggia, Italy; ²Humanitas University, Rozzano, Italy; ³IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; ⁴First Sechenov University, Russia; ⁵Santa Maria Hospital, Bari, Italy; ⁶Angiologia, Faenza, Italy; ⁷Momo Fertilife, Bisceglie, Italy; ⁸Brigham Women Hospital, USA; ⁹Queen’s University, Kingston, Canada

  22-10-2025

  https://doi.org/10.4081/btvb.2025.310

  572

  PDF: 14
• 

  OC04 | DIRECT ORAL ANTICOAGULANTS PROVIDE EFFECTIVE THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA: REAL WORLD FINDINGS FROM THE ATOMM STUDY T. Bull¹, Heamstar Collaborators², W. Wilson³, E. Ganendra⁴, M. Thomas⁵, R. Alikhan⁶, M. Karanth¹, M. Camilleri⁷ | ¹West Suffolk Hospital NHS Foundation Trust, UK; ²Haematology Specialty Training Audit and Research HaemSTAR Network, UK; ³University College London Clinical Trial Centre, UK; ⁴North West Anglia NHS Foundation Trust, UK; ⁵University College London Hospitals, UK; ⁶Cardiff and Vale University Health Board, Wales, UK; ⁷Cambridge University Hospitals NHS Foundation Trust, UK

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.488

  616

  PDF: 135
• 

  Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

  Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

  16-05-2024

  https://doi.org/10.4081/btvb.2024.114

  1060

  PDF: 1143

• PO128 | FROM SEVERE THROMBOSIS TO SUCCESSFUL PREGNANCIES: ORTHOTOPIC LIVER TRANSPLANTATION IN INHERITED AFIBRINOGENEMIA WITH BUDD–CHIARI SYNDROME G. Murante^1|2|6, S. Bergonzi^1|2|6, M. Capetta^1|2|6, F. Valeri^1|2, C. Dainese^1|2, A. Valpreda⁴, R. Pastorino^1|6, F. Bocchi^1|6, R. Romagnoli⁵, S. Martini³, B. Bruno^2|6, A. Borchiellini^1|2 | ¹Regional Centre for Hemorrhagic and Thrombotic Diseases; ²Division of Hematology; ³SSD Hepatic insufficiency and Liver Transplant; ⁴Central Lab. Baldi and Riberi; ⁵General Surgery 2U - Liver Transplant Center, Molinette Hospital, AOU Città della Salute e della Scienza di Torino, Italy; ⁶Dep. of Molecular Biotechnology and Health Sciences, University of Turin, Italy

  Giovanni Murante

  26-10-2026

  https://doi.org/10.4081/btvb.2026.944

  2

  PDF: 2
• 

  PO31 | MIGRATORY SUPERFICIAL THROMBOPHLEBITIS REFRACTORY TO APIXABAN IN A PATIENT WITH LUNG ADENOCARCINOMA I. Goldberg^1|2, P. Raanani^1|2|3, G. Spectre^1|2 | ¹Institute of Hematology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel; ²Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel; ³Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel

  ICTHIC 2026

  16-04-2026

  https://doi.org/10.4081/btvb.2026.526

  492

  PDF: 100

• CO07 | Real word management of anticoagulant therapy in brain metastasis: moving toward a multidisciplinary approach in complex cases E. Lotti¹, C. Manneschi², S. Fancelli², F. Scolari¹, F. Crudele¹, D. Poli¹, M. Berteotti¹, D. Rossini³, S. Pillozzi², L. Antonuzzo^2,3, R. Marcucci^1,3 | ¹Disease Unit, Careggi University Hospital, Firenze; ²Oncology Unit, Careggi University Hospital, Firenze; ³Department of Experimental and Clinical Biomedical Sciences, University of Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.211

  619

  PDF: 20

• PO011 | A TWO CENTERS REAL-WORLD EXPERIENCE WITH ANTI-XA DIRECT ORAL ANTICOAGULANTS IN CANCER PATIENTS WITH UNUSUAL SITE VEIN THROMBOSIS U. Mazzarelli¹, L. Agrelli¹, A. Cirillo¹, C. Caputo², M. Romano², R. Russo², R. Guarrasi³, M. Triggiani¹, A. Tufano², A. Guida⁴ | ¹Dipartimento di Medicina Interna, Università degli studi di Salerno, Italy; ²Dipartimento di Medicina Interna, Università degli studi di Napoli Federico II, Italy; ³UOC Clinica Oncologica; ⁴Centro per le malattie emorragiche congenite e malattie trombotiche AOU San Giovanni di Dio e Ruggi d'Aragona Salerno, Italy

  Anna Guida

  26-10-2026

  https://doi.org/10.4081/btvb.2026.827

  6

  PDF: 2